Navigation Links
Amicus Therapeutics Announces Second Quarter 2007 Financial Results
Date:8/19/2007

(10,284) (17,599) (20,516) (105,117)

Other income

(expenses):

Interest income 448 1,060 686 1,753 4,560

Interest expense (74) (86) (125) (179) (1,261)

Change in fair

value of warrant

Liability 471 (86) 127 (149) (454)

Other expense 2 - (1) - (1,181)

Loss before

tax benefit (8,624) (9,396) (16,912) (19,091) (103,453)

Income tax benefit - - - - 695

Net loss (8,624) (9,396) (16,912) (19,091) (102,758)

Deemed dividend (19,424) - (19,424) - (19,424)

Preferred stock

accretion (41) (310) (81) (351) (802)

Net loss

attributable

to common

stockholders $(28,089) $(9,706) $(36,417) $(19,442) $(122,984)

Net loss

attributable

to common

stockholders per

common share --

basic and diluted $(39.04) $(1.37) $(57.78) $(4.80)

Weighted-average

common shares

outstanding --

basic and

diluted 719,556 7,083,748 630,230 4,051,709

See accompanying notes to consolidated financial statements

Amicus Therapeutics, Inc

Statement of Operations Information for 3 months ending June 30, 2007

Change in

Fair

Value of Preferred Stock

Warrant Stock Compen- GAAP as

Non-GAAP Liability Accretion sation Reported

Income Statement

Classifications:

Research and development (6,361)
'/>"/>

SOURCE Amicus Therapeutics

Copyright©2007 PR Newswire.

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Amicus Therapeutics Presents Positive Results From Phase 1 Clinical Studies of Plicera for Gaucher Disease
2. Amicus Therapeutics Presents Preclinical Data from Studies of Plicera for Gaucher Disease
3. Amicus Therapeutics Presents Data From Preclinical and Phase 1 Studies of Amigal for Fabry Disease
4. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
5. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
6. CV Therapeutics Identifies Potential Anti-Diabetic Mechanism of Action for Ranexa
7. GTC Biotherapeutics to Webcast Corporate Presentation at the C.E. Unterberg, Towbin Emerging Growth Life Opportunities Conference
8. Fat Kills Cancer: Turning Stem Cells from Fat Tissue into Personalized, Cancer-Targeted Therapeutics
9. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
10. Clinical Trial Suggests Bone Marrow Stem Cells Are Useful for Spinal Cord Injury; PrimeCell Therapeutics Provided Pre-Clinical Study
11. Pieris Progresses Development of its Proprietary Biotherapeutics Platform: Successful Demonstration of Dual Targeting With Duocalin(R) Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/29/2015)... 2015 Axxess , an industry leader ... software vendor accredited by the American Nursing Credentialing Center ... health agencies select the right revenue cycle management (RCM) ... their business. Research by American Health Information ... expect a decrease in productivity of 54.4 - 69 ...
(Date:6/29/2015)... 29, 2015 The Parenteral Drug Association is ... Board of Professional Engineers and Land Surveyors ... to professional engineers for continuing professional competency (CPC) credits. ... value and quality of PDA,s professional education offerings," said ... and hands-on professional training at the Training and Research ...
(Date:6/29/2015)... EASTON, Mass. , June 29, 2015 /PRNewswire/ ... "Company"), a leader in the development and sale ... preparation solutions to the worldwide life sciences industry, ... the Institute of Molecular Systems Biology, ETH Zurich, ... proteomic profiling and classification of prostate cancer tissue ...
Breaking Medicine Technology:Axxess Releases eGuide for Home Health Agencies, Revenue Cycle Management: What You Must Do Now - to Succeed! 2Better Classification of Prostate Cancer Tissue Biopsy Samples Enabled by Pressure BioSciences' PCT Platform 2Better Classification of Prostate Cancer Tissue Biopsy Samples Enabled by Pressure BioSciences' PCT Platform 3Better Classification of Prostate Cancer Tissue Biopsy Samples Enabled by Pressure BioSciences' PCT Platform 4
... Feb. 21, 2012 A collaboration between NineSigma and ... advance HIV vaccine research by identifying new approaches to ... provider of innovation services , NineSigma has connected ... and helped it identify two scientists who will receive ...
... #8116 -- Precyse, a leader in health information ... HIMSS 2012 Annual Conference and Exposition that the ... improvements in revenue cycle workflow, coding accuracy, and ... adopting Precyse,s integrated health information management (HIM) and ...
Cached Medicine Technology:IAVI and NineSigma Collaborate to Identify New Approaches to Developing AIDS Vaccines 2IAVI and NineSigma Collaborate to Identify New Approaches to Developing AIDS Vaccines 3IAVI and NineSigma Collaborate to Identify New Approaches to Developing AIDS Vaccines 4Growing List of Providers Accelerate Revenue Cycles, Improve Clinical Documentation Through True Computer-Assisted Coding with Natural Language Comprehension™ 2Growing List of Providers Accelerate Revenue Cycles, Improve Clinical Documentation Through True Computer-Assisted Coding with Natural Language Comprehension™ 3Growing List of Providers Accelerate Revenue Cycles, Improve Clinical Documentation Through True Computer-Assisted Coding with Natural Language Comprehension™ 4
(Date:6/30/2015)... ... June 30, 2015 , ... Izenda is proud ... who are currently attending an accredited American educational institution through its scholarship program. ... insight into healthcare, the environment, political campaigns, and a variety of other worldwide ...
(Date:6/30/2015)... ... June 30, 2015 , ... This Fourth of July, Peacock Alley ... story including hard work, tenacity, perseverance, commitment to quality, honesty and love of friends ... of Mary Ella Gabler's simple love of quilts, Peacock Alley was fully realized and ...
(Date:6/30/2015)... ... June 30, 2015 , ... “It is never too early to be proactive ... particularly interested in getting the word out to children because sun damage is cumulative ... are extremely pleased with our new video which we feel is a fun way ...
(Date:6/29/2015)... Topsfield, MA (PRWEB) , ... June 30, 2015 ... ... in Connecticut in early November at one of the industry’s premier thought leadership ... over 250 administrators, directors of nursing, rehabilitation managers and other management and corporate ...
(Date:6/29/2015)... ... ... Ticket Down is a reputable source for authentic Grateful Dead tickets ... can add promo/coupon code GRATEFUL-DEAD-2015 for added savings. , Long-time fans of "The Dead" ... want to miss what is sure to be history in the making. Over the ...
Breaking Medicine News(10 mins):Health News:Izenda Offers Embedded BI and Analytics Scholarship 2Health News:Izenda Offers Embedded BI and Analytics Scholarship 3Health News:Luxury Linen Purveyor Peacock Alley Celebrates the Fourth of July 2Health News:SunGrubbies.com, a Leading Online Retailer of Sun Protection Products, Joins Effort to Promote Sun Safety 2Health News:SunGrubbies.com, a Leading Online Retailer of Sun Protection Products, Joins Effort to Promote Sun Safety 3Health News:Gov. Mark Parkinson, President and CEO of AHCA/NCAL to Give Keynote Address at Harmony 2015 2Health News:Gov. Mark Parkinson, President and CEO of AHCA/NCAL to Give Keynote Address at Harmony 2015 3Health News:Grateful Dead Tickets at Soldier Field in Chicago: Ticket Down Slashes Grateful Dead Tickets Prices in Chicago at Soldier Field 2Health News:Grateful Dead Tickets at Soldier Field in Chicago: Ticket Down Slashes Grateful Dead Tickets Prices in Chicago at Soldier Field 3
... NORWALK, Conn., Oct. 27 Maclaren USA Inc.,announces the ... Chief Operation Officer., "Maclaren,s growth has been extraordinary ... our new from-birth transport system, the Grand Tour(TM),LX, is ... proven themselves to be exceptional leaders in their field. ...
... are turning 62,every seven seconds. Many are now ... in their senior years, says Frank N. Darras, ... (Photo: http://www.newscom.com/cgi-bin/prnh/20070717/NYFNSC02 ), Senior health ... been sold and,marketed to our grandparents with a ...
... Defibrillator (AED) to Habitat for Humanity, through Logistics Corporation. ... ... 2008 -- HeartSine Technologies, a leading supplier of public access ... (AED) to Habitat for Humanity, through Logistics Corporation, a re-distributor ...
... years ago, a large biotech company began collecting ... proven tablet system in clinical trials around the ... of using the assisTek system compared to what ... used traditional paper questionnaires. The results showed that ...
... belly fat , , SUNDAY, Oct. 26 (HealthDay News) -- ... research ties eating tart cherries to lowering cholesterol, reducing ... all major risk factors for heart disease. , This ... Michigan researchers at the American Dietetic Association annual meeting, ...
... its popular embedded database Raima Database Manager Embedded 9.0. , ... ... BIRD) today announced the upcoming release of version 9.0 of its ... the latest release from the Raima Database Management Family providing exciting ...
Cached Medicine News:Health News:Maclaren Appoints New President and New Chief Operation Officer 2Health News:Expert Says Conseco Trust May Significantly Alter The Senior Health Care Market 2Health News:HeartSine Portable Defibrillator Donation Brings Added Safety to Habitat for Humanity of Charlotte ReStore Location 2Health News:assisTek's ePRO Biotech Clinical Trial Data Collection Saves Client $1.6 Million Over Paper Questionnaires 2Health News:Cherry-Enriched Diet Cut Heart Risks in Rats 2Health News:Birdstep Technology Adds Micro HTTP Server to the Upcoming Release of its Raima Database Manager, RDM Embedded Version 9.0 2Health News:Birdstep Technology Adds Micro HTTP Server to the Upcoming Release of its Raima Database Manager, RDM Embedded Version 9.0 3
The 16 liter Laparoscopy Insufflator combines high safety and precise pressure control with simple operation....
The TurboFlow 8000 has two separate gas output ports which, unlike many high flow insufflators, use standard-size tubing, each capable of providing up to 20 LPM flow....
... GenoID's kit is the first commercially ... for clinical diagnostic use. , ,The ... and 5 low-risk genotypes of HPV ... PCR technology but simplifying the process ...
... An in vitro Nucleic ... Amplification using Microplate Chemiluminescence for ... Papillomavirus (HPV) Types 6,11,16,18,31,33,35,39,42,43,44,45,51,52,56,58,59 and ... DNA Lowand High-Risk Groups in ...
Medicine Products: